Depression最新文献

筛选
英文 中文
Rapid cycling triggered by pindolol augmentation of paroxetine, but not with desipramine 匹多洛尔增加帕罗西汀可触发快速循环,但地西帕明不会
Depression Pub Date : 1996-01-01 DOI: 10.1002/(SICI)1522-7162(1996)4:2<92::AID-DEPR10>3.0.CO;2-F
Robert P. Kraus M.D., F.R.C.P.(c)
{"title":"Rapid cycling triggered by pindolol augmentation of paroxetine, but not with desipramine","authors":"Robert P. Kraus M.D., F.R.C.P.(c)","doi":"10.1002/(SICI)1522-7162(1996)4:2<92::AID-DEPR10>3.0.CO;2-F","DOIUrl":"10.1002/(SICI)1522-7162(1996)4:2<92::AID-DEPR10>3.0.CO;2-F","url":null,"abstract":"<p>A treatment-resistant depressed patient developed bipolar rapid cycling in response to pindolol augmentation of paroxetine, after failing to respond in any fashion to pindolol added to desipramine. The rapid cycling initially faded, but recurred after the pindolol dose was increased (in combination with paroxetine) in an attempt to treat a relapse into depression. Her differential development of rapid cycling with pindolol in combination with the SSRI is in keeping with the theory that pindolol augmentation operates via a serotonergic mechanism. Depression 4:92–94 (1996). © 1997 Wiley-Liss, Inc.</p>","PeriodicalId":11179,"journal":{"name":"Depression","volume":"4 2","pages":"92-94"},"PeriodicalIF":0.0,"publicationDate":"1996-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/(SICI)1522-7162(1996)4:2<92::AID-DEPR10>3.0.CO;2-F","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20107297","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
Venlafaxine: A novel antidepressant that has a dual mechanism of action 文拉法辛:一种具有双重作用机制的新型抗抑郁药
Depression Pub Date : 1996-01-01 DOI: 10.1002/(SICI)1522-7162(1996)4:2<48::AID-DEPR2>3.0.CO;2-B
James M. Andrews M.D., Philip T. Ninan M.D., Charles B. Nemeroff M.D., Ph.D.
{"title":"Venlafaxine: A novel antidepressant that has a dual mechanism of action","authors":"James M. Andrews M.D.,&nbsp;Philip T. Ninan M.D.,&nbsp;Charles B. Nemeroff M.D., Ph.D.","doi":"10.1002/(SICI)1522-7162(1996)4:2<48::AID-DEPR2>3.0.CO;2-B","DOIUrl":"10.1002/(SICI)1522-7162(1996)4:2<48::AID-DEPR2>3.0.CO;2-B","url":null,"abstract":"<p>Major depressive disorder (MDD) is a common affective disorder that is associated with a range of psychiatric disturbances. The pathophysiology of MDD is commonly believed to involve the reduced availability of the monoamines, serotonin (5-HT) and norepinephrine (NE), the enhancement of which is also believed to mediate, at least in part, the therapeutic effects of antidepressants. The first-generation antidepressants, the tricyclic antidepressants (TCAs), provide considerable efficacy but have several limitations, including (1) delayed onset of action, (2) intolerable or distressing side effects, (3) low therapeutic index, and (4) a significant proportion of nonresponders. The second-generation antidepressants, the selective-serotonin-reuptake inhibitors (SSRIs), mitigate some of the side effects associated with the TCAs by selectively inhibiting the reuptake of 5-HT. Venlafaxine is a new antidepressant that blocks reuptake of both 5-HT and NE. It, like the SSRIs, has a relatively benign side-effect profile. In addition, it may exert a rapid onset of action, and it appears to be particularly effective in moderate-to-severe depression and in patients who have treatment-refractory depression. Depression 4:48–56 (1996). © 1997 Wiley-Liss, Inc.</p>","PeriodicalId":11179,"journal":{"name":"Depression","volume":"4 2","pages":"48-56"},"PeriodicalIF":0.0,"publicationDate":"1996-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/(SICI)1522-7162(1996)4:2<48::AID-DEPR2>3.0.CO;2-B","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20107982","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 79
Depressive symptoms: Associations with health perceptions and health behaviors 抑郁症状:与健康认知和健康行为的关系
Depression Pub Date : 1996-01-01 DOI: 10.1002/(SICI)1522-7162(1996)4:2<68::AID-DEPR5>3.0.CO;2-B
Denis Lynch Ph.D., Marijo Tamburrino M.D., Rollin Nagel M.A.
{"title":"Depressive symptoms: Associations with health perceptions and health behaviors","authors":"Denis Lynch Ph.D.,&nbsp;Marijo Tamburrino M.D.,&nbsp;Rollin Nagel M.A.","doi":"10.1002/(SICI)1522-7162(1996)4:2<68::AID-DEPR5>3.0.CO;2-B","DOIUrl":"10.1002/(SICI)1522-7162(1996)4:2<68::AID-DEPR5>3.0.CO;2-B","url":null,"abstract":"<p>The association of depressive symptoms with health behaviors and perceptions was determined for 876 patients seeing family physicians. Correlational analyses revealed stress, pain, and overall health status were moderately related to depression for males and females. Smoking was positively related to depressive symptoms in women (r = .19, <i>P</i> &lt;.001), and drinking was inversely related to depressive symptoms in men (r = −.16, <i>P</i> &lt;.01). Multiple regression analyses indicated stress, poor health, smoking, and drinking were significant predictors of depressive symptoms in women; stress, poor health, and drinking were significant in men. Health perceptions appear to be better predictors of depressive symptoms than reported health behaviors. Depression 4:68–72 (1996). © 1997 Wiley-Liss, Inc.</p>","PeriodicalId":11179,"journal":{"name":"Depression","volume":"4 2","pages":"68-72"},"PeriodicalIF":0.0,"publicationDate":"1996-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/(SICI)1522-7162(1996)4:2<68::AID-DEPR5>3.0.CO;2-B","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20107292","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
Do patients use marijuana as an antidepressant? 病人会把大麻当作抗抑郁药吗?
Depression Pub Date : 1996-01-01 DOI: 10.1002/(SICI)1522-7162(1996)4:2<77::AID-DEPR7>3.0.CO;2-C
Amanda J. Gruber M.D., Harrison G. Pope Jr. M.D., Michael E. Brown M.D.
{"title":"Do patients use marijuana as an antidepressant?","authors":"Amanda J. Gruber M.D.,&nbsp;Harrison G. Pope Jr. M.D.,&nbsp;Michael E. Brown M.D.","doi":"10.1002/(SICI)1522-7162(1996)4:2<77::AID-DEPR7>3.0.CO;2-C","DOIUrl":"10.1002/(SICI)1522-7162(1996)4:2<77::AID-DEPR7>3.0.CO;2-C","url":null,"abstract":"<p>Several lines of evidence suggest that cannabis may have antidepressant effects. However, methodologic limitations in available studies make the results difficult to interpret. We review this literature and present five cases in which the evidence seems particularly clear that marijuana produced a direct antidepressant effect. If true, these observations argue that many patients may use marijuana to “self-treat” depressive symptoms. Depression 4:77–80 (1996). © 1997 Wiley-Liss, Inc.</p>","PeriodicalId":11179,"journal":{"name":"Depression","volume":"4 2","pages":"77-80"},"PeriodicalIF":0.0,"publicationDate":"1996-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/(SICI)1522-7162(1996)4:2<77::AID-DEPR7>3.0.CO;2-C","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20107294","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 105
Lack of association between thyroid and pineal responses to antidepressant treatment 甲状腺和松果体对抗抑郁治疗的反应缺乏相关性
Depression Pub Date : 1996-01-01 DOI: 10.1002/(SICI)1522-7162(1996)4:2<73::AID-DEPR6>3.0.CO;2-G
G.M. Brown M.D., Ph.D., W. Singer M.B., B.S., R. Joffe M.D.
{"title":"Lack of association between thyroid and pineal responses to antidepressant treatment","authors":"G.M. Brown M.D., Ph.D.,&nbsp;W. Singer M.B., B.S.,&nbsp;R. Joffe M.D.","doi":"10.1002/(SICI)1522-7162(1996)4:2<73::AID-DEPR6>3.0.CO;2-G","DOIUrl":"10.1002/(SICI)1522-7162(1996)4:2<73::AID-DEPR6>3.0.CO;2-G","url":null,"abstract":"<p>With antidepressant treatment for major depression there are decreases in thyroid hormone levels and increases in pineal function. We have conducted a study to examine whether there is a relationship between pineal and thyroid hormone measures as well as between hormone measures and response to treatment in patients treated with desipramine. Measures of thyroid activity included thyroxine, triiodothyronine, T3 resin uptake, and TSH. Pineal function was determined by measurement of 6-suphatoxymelatonin in three consecutive 8 hour pools. Hormone measures as well as Hamilton depression scores were obtained prior to treatment and at the end of 5 weeks of treatment. As in previous studies, thyroid measures decreased, pineal activity increased, and Hamilton scores decreased significantly with treatment. No correlations were found between these measures, suggesting that if there is a relationship between them it is not a direct one. Depression 4:73–76 (1996). © 1997 Wiley-Liss, Inc.</p>","PeriodicalId":11179,"journal":{"name":"Depression","volume":"4 2","pages":"73-76"},"PeriodicalIF":0.0,"publicationDate":"1996-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/(SICI)1522-7162(1996)4:2<73::AID-DEPR6>3.0.CO;2-G","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20107293","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
An empirical study of the psychodynamics of suicide: A preliminary report 自杀心理动力学的实证研究:初步报告
Depression Pub Date : 1996-01-01 DOI: 10.1002/(SICI)1522-7162(1996)4:2<89::AID-DEPR9>3.0.CO;2-A
Susan E. Chance M.A., Susan L. Reviere M.A., James H. Rogers Ph.D., Mark E. James M.D., Salley Jessee M.D., Lisseth Rojas M.A., Carrie A. Hatcher B.A., Nadine J. Kaslow Ph.D.
{"title":"An empirical study of the psychodynamics of suicide: A preliminary report","authors":"Susan E. Chance M.A.,&nbsp;Susan L. Reviere M.A.,&nbsp;James H. Rogers Ph.D.,&nbsp;Mark E. James M.D.,&nbsp;Salley Jessee M.D.,&nbsp;Lisseth Rojas M.A.,&nbsp;Carrie A. Hatcher B.A.,&nbsp;Nadine J. Kaslow Ph.D.","doi":"10.1002/(SICI)1522-7162(1996)4:2<89::AID-DEPR9>3.0.CO;2-A","DOIUrl":"10.1002/(SICI)1522-7162(1996)4:2<89::AID-DEPR9>3.0.CO;2-A","url":null,"abstract":"<p>Preliminary results from a study of psychodynamic constructs are presented based on data from inpatients following a suicide attempt. The study examines the association between four psychodynamic constructs, severity of suicidal intent, and severity of depressive symptomatology in a sample of hospitalized suicide attempters. Higher levels of suicidal intent were associated with less differentiated self and object representations and less emotional investment in relationships. More severe depressive symptoms in suicide attempters were correlated with more self-targeted anger; less eternally directed anger, higher levels of shame and guilt, more affectively negative views of relationships, greater use of maladaptive and self-sacrificing defenses, and more impaired reality testing. These findings offer some preliminary empirical support for the validity of psychodynamic theories of suicidal behavior. Depression 4:89–91 (1996). © 1997 Wiley-Liss, Inc.</p>","PeriodicalId":11179,"journal":{"name":"Depression","volume":"4 2","pages":"89-91"},"PeriodicalIF":0.0,"publicationDate":"1996-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/(SICI)1522-7162(1996)4:2<89::AID-DEPR9>3.0.CO;2-A","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20107296","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 17
Trimipramine and imipramine exert different effects on the sleep EEG and on nocturnal hormone secretion during treatment of major depression 重度抑郁症治疗期间,三氯丙嗪与丙咪嗪对睡眠脑电图及夜间激素分泌的影响不同
Depression Pub Date : 1996-01-01 DOI: 10.1002/(SICI)1522-7162(1996)4:1<1::AID-DEPR1>3.0.CO;2-S
Annette Sonntag M.D., Barbara Rothe M.D., Jürgen Guldner M.D., Alexander Yassouridis PhD., Florian Holsboer M.D., Ph.D., Axel Steiger M.D.
{"title":"Trimipramine and imipramine exert different effects on the sleep EEG and on nocturnal hormone secretion during treatment of major depression","authors":"Annette Sonntag M.D.,&nbsp;Barbara Rothe M.D.,&nbsp;Jürgen Guldner M.D.,&nbsp;Alexander Yassouridis PhD.,&nbsp;Florian Holsboer M.D., Ph.D.,&nbsp;Axel Steiger M.D.","doi":"10.1002/(SICI)1522-7162(1996)4:1<1::AID-DEPR1>3.0.CO;2-S","DOIUrl":"10.1002/(SICI)1522-7162(1996)4:1<1::AID-DEPR1>3.0.CO;2-S","url":null,"abstract":"<p>In a 4-week double-blind clinical trial we compared the effects of the tricyclic antidepressants trimipramine and imipramine on the sleep EEG and on nocturnal hormone secretion in 20 male inpatients with major depression. Both treatments produced rapid significant clinical improvement in depression without severe adverse effects. However, the two drugs had markedly different neurobiologic profiles. Trimipramine enhanced rapid eye movement (REM) sleep and slow wave sleep, whereas imipramine suppressed REM sleep and showed no effect on slow wave sleep. Total sleep time and the sleep efficiency index increased under trimipramine but not under imipramine. Nocturnal cortisol secretion decreased with trimipramine but remained unchanged with imipramine. In contrast to imipramine, trimipramine induced an increase in prolactin secretion compatible with its known antagonism at dopamine (D<sub>2</sub>) receptors. Imipramine induced a decrease in growth hormone secretion during the first half of the night. Neither of the drugs induced significant changes in plasma testosterone concentration. We conclude that trimipramine is an antidepressant with sleep-improving qualities that possibly acts through inhibition of hypothalamic-pituitary-adrenocortical system activity by a yet unknown mechanism. Depression 4:1-13 (1996). © 1996 Wiley-Liss, Inc.</p>","PeriodicalId":11179,"journal":{"name":"Depression","volume":"4 1","pages":"1-13"},"PeriodicalIF":0.0,"publicationDate":"1996-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/(SICI)1522-7162(1996)4:1<1::AID-DEPR1>3.0.CO;2-S","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20107298","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 79
Cognitive therapy versus fluoxetine in the treatment of dysthymic disorder 认知疗法与氟西汀治疗心境恶劣障碍的比较
Depression Pub Date : 1996-01-01 DOI: 10.1002/(SICI)1522-7162(1996)4:1<34::AID-DEPR4>3.0.CO;2-F
David L. Dunner M.D., Karen B. Schmaling Ph.D., Helen Hendrickson M.D., Joseph Becker Ph.D., Adam Lehman Ph.D., Carolyn Bea B.S.
{"title":"Cognitive therapy versus fluoxetine in the treatment of dysthymic disorder","authors":"David L. Dunner M.D.,&nbsp;Karen B. Schmaling Ph.D.,&nbsp;Helen Hendrickson M.D.,&nbsp;Joseph Becker Ph.D.,&nbsp;Adam Lehman Ph.D.,&nbsp;Carolyn Bea B.S.","doi":"10.1002/(SICI)1522-7162(1996)4:1<34::AID-DEPR4>3.0.CO;2-F","DOIUrl":"10.1002/(SICI)1522-7162(1996)4:1<34::AID-DEPR4>3.0.CO;2-F","url":null,"abstract":"<p>We studied the effects of a fixed dose of fluoxetine (20 mg) or cognitive psycho-therapy in a 16 week trial of patients with dysthymic disorder. More patients assigned to fluoxetine dropped out of the 16 week treatment (33%) than those assigned to cognitive therapy (9%), but this difference did not attain statistical significance. Both treatments showed improvement over baseline conditions at 8 weeks and further improvement at 16 weeks. There were no statistically significant group differences in treatment response. No follow-up data were collected so the enduring effects of the treatments are unknown. An optimal treatment for dysthymic disorder may be combined psychotherapy and pharmacotherapy for a longer period of time. Depression 4:34-41 (1996). © 1996 Wiley-Liss, Inc.</p>","PeriodicalId":11179,"journal":{"name":"Depression","volume":"4 1","pages":"34-41"},"PeriodicalIF":0.0,"publicationDate":"1996-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/(SICI)1522-7162(1996)4:1<34::AID-DEPR4>3.0.CO;2-F","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20108364","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 65
Depression in patients with coronary artery disease 冠状动脉疾病患者的抑郁
Depression Pub Date : 1996-01-01 DOI: 10.1002/(SICI)1522-7162(1996)4:2<57::AID-DEPR3>3.0.CO;2-C
Michael B. Gonzalez B.S., Ted B. Snyderman B.A., Jeffrey T. Colket B.S., Rebekka M. Arias B.S., Jan W. Jiang M.D., Christopher M. O'Connor M.D., K. Ranga Krishnan M.D.
{"title":"Depression in patients with coronary artery disease","authors":"Michael B. Gonzalez B.S.,&nbsp;Ted B. Snyderman B.A.,&nbsp;Jeffrey T. Colket B.S.,&nbsp;Rebekka M. Arias B.S.,&nbsp;Jan W. Jiang M.D.,&nbsp;Christopher M. O'Connor M.D.,&nbsp;K. Ranga Krishnan M.D.","doi":"10.1002/(SICI)1522-7162(1996)4:2<57::AID-DEPR3>3.0.CO;2-C","DOIUrl":"10.1002/(SICI)1522-7162(1996)4:2<57::AID-DEPR3>3.0.CO;2-C","url":null,"abstract":"<p>Depression is more prevalent in patients with coronary artery disease (CAD) than in the general elderly population. Although CAD patients with depression have higher mortality rates, depression is often not recognized and treated in these patients. We administered structured psychiatric diagnostic interviews to 99 inpatients with CAD and diagnosed 23% with a major depressive episode (MDE) by DSM-IV criteria. Severity of medical illness and family history of psychopathology were indicators for increased risk for MDE. These findings may facilitate the recognition of CAD patients at greater risk for MDE. Depression 4:57–62 (1996). © 1997 Wiley-Liss, Inc.</p>","PeriodicalId":11179,"journal":{"name":"Depression","volume":"4 2","pages":"57-62"},"PeriodicalIF":0.0,"publicationDate":"1996-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/(SICI)1522-7162(1996)4:2<57::AID-DEPR3>3.0.CO;2-C","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20107983","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 141
Six month follow-up of early-onset chronic depression 对早发性慢性抑郁症患者进行6个月的随访
Depression Pub Date : 1996-01-01 DOI: 10.1002/(SICI)1522-7162(1996)4:2<63::AID-DEPR4>3.0.CO;2-G
Vito Agosti M.S.W., Jonathan W. Stewart M.D.
{"title":"Six month follow-up of early-onset chronic depression","authors":"Vito Agosti M.S.W.,&nbsp;Jonathan W. Stewart M.D.","doi":"10.1002/(SICI)1522-7162(1996)4:2<63::AID-DEPR4>3.0.CO;2-G","DOIUrl":"10.1002/(SICI)1522-7162(1996)4:2<63::AID-DEPR4>3.0.CO;2-G","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>This study sought to characterize the morbidity and treatment behavior of 49 patients with early-onset chronic depression, 6 months after terminating treatment at a university-based psychopharmacology research clinic.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Method</h3>\u0000 \u0000 <p>Patients with and without early-onset chronic depression were selected to participate in a naturalistic follow-up study. Assessments were conducted blind to patients' histories. Patients' depressive symptoms, psychosocial functioning, and post-discharge treatment histories were assessed.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>After termination, the mean length of recovery for the sample was 3.6 months. When they left the clinic, 78% (38/49) were euthymic. At follow-up, 37% (14/38) of these had relapsed; while 45% (17/38) remained in remission for 6 months. During the follow-up period, 47% of the patients were on antidepressants.</p>\u0000 \u0000 <p>Sixty-three percent of the patients who relapsed, or were depressed when they left the clinic, did not enter treatment, 50% of whom cited insufficient resources as the primary reason for not receiving care.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>After leaving a depression research clinic, a substantial portion of patients with early-onset chronic depression remained recovered during a 6-month period, but financial impediments prevented a majority of those who did poorly from entering treatment. Depression 4:63–67 (1996). © 1997 Wiley-Liss, Inc.</p>\u0000 </section>\u0000 </div>","PeriodicalId":11179,"journal":{"name":"Depression","volume":"4 2","pages":"63-67"},"PeriodicalIF":0.0,"publicationDate":"1996-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/(SICI)1522-7162(1996)4:2<63::AID-DEPR4>3.0.CO;2-G","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20107984","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信